SGS742: the first GABAB receptor antagonist in clinical trials

Biochemical Pharmacology - Tập 68 - Trang 1479-1487 - 2004
Wolfgang Froestl1, Michela Gallagher2, Helen Jenkins3, Annette Madrid3, Thorsten Melcher3, Sam Teichman3, Cesare G. Mondadori4, Rodney Pearlman3
1Neuroscience Research, Novartis Pharma AG, WKL-136.5.25, CH-4002 Basel, Switzerland
2Department of Psychology, Johns Hopkins University, Baltimore, MD 21218, USA
3Saegis Pharmaceuticals, Inc., Half Moon Bay, CA 94019, USA
4Neuro3D SA, F-68086 Mulhouse, France

Tài liệu tham khảo